JP2023533693A5 - - Google Patents
Info
- Publication number
- JP2023533693A5 JP2023533693A5 JP2022580238A JP2022580238A JP2023533693A5 JP 2023533693 A5 JP2023533693 A5 JP 2023533693A5 JP 2022580238 A JP2022580238 A JP 2022580238A JP 2022580238 A JP2022580238 A JP 2022580238A JP 2023533693 A5 JP2023533693 A5 JP 2023533693A5
- Authority
- JP
- Japan
- Prior art keywords
- xyl
- rha
- fuc
- glc
- saponin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026073994A JP2026126321A (ja) | 2020-06-24 | 2026-04-27 | GalNAc-オリゴヌクレオチドコンジュゲート及びサポニンの治療用配合物、及びその使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL2025902 | 2020-06-24 | ||
| NL2025902 | 2020-06-24 | ||
| PCT/NL2021/050384 WO2021261992A1 (en) | 2020-06-24 | 2021-06-18 | Conjugate of galnac and saponin, therapeutic composition comprising said conjugate and a galnac-oligonucleotide conjugate |
| NLPCT/NL2021/050384 | 2021-06-18 | ||
| PCT/NL2021/050394 WO2021261998A1 (en) | 2020-06-24 | 2021-06-23 | Therapeutic combination of galnac-oligonucleotide conjugate and saponin, and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026073994A Division JP2026126321A (ja) | 2020-06-24 | 2026-04-27 | GalNAc-オリゴヌクレオチドコンジュゲート及びサポニンの治療用配合物、及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023533693A JP2023533693A (ja) | 2023-08-04 |
| JP2023533693A5 true JP2023533693A5 (cg-RX-API-DMAC10.html) | 2024-07-01 |
| JP7862331B2 JP7862331B2 (ja) | 2026-05-19 |
Family
ID=72087123
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022580238A Active JP7862331B2 (ja) | 2020-06-24 | 2021-06-23 | GalNAc-オリゴヌクレオチドコンジュゲート及びサポニンの治療用配合物、及びその使用 |
| JP2026073994A Pending JP2026126321A (ja) | 2020-06-24 | 2026-04-27 | GalNAc-オリゴヌクレオチドコンジュゲート及びサポニンの治療用配合物、及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026073994A Pending JP2026126321A (ja) | 2020-06-24 | 2026-04-27 | GalNAc-オリゴヌクレオチドコンジュゲート及びサポニンの治療用配合物、及びその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230293562A1 (cg-RX-API-DMAC10.html) |
| EP (2) | EP4596052A3 (cg-RX-API-DMAC10.html) |
| JP (2) | JP7862331B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR20230044196A (cg-RX-API-DMAC10.html) |
| CN (1) | CN116194148A (cg-RX-API-DMAC10.html) |
| IL (1) | IL299349A (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026060043A1 (en) * | 2024-09-10 | 2026-03-19 | Xact Bio, Inc. | Compositions and methods for targeting a tissue specific protein expression |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2522213A1 (en) * | 2003-04-08 | 2004-10-28 | Dante J. Marciani | Semi-synthetic saponin analogs with carrier and immune stimulatory activities for dna and rna vaccines |
| WO2011054811A1 (en) * | 2009-11-03 | 2011-05-12 | Santaris Pharma A/S | Rna antagonists targeting hsp27 combination therapy |
| KR20160083876A (ko) * | 2013-11-14 | 2016-07-12 | 로슈 이노베이션 센터 코펜하겐 에이/에스 | ApoB 안티센스 접합체 화합물 |
| US20220023433A1 (en) * | 2018-12-21 | 2022-01-27 | Sapreme Technologies B.V. | Saponin Conjugates |
-
2021
- 2021-06-23 EP EP25178184.5A patent/EP4596052A3/en active Pending
- 2021-06-23 KR KR1020237002644A patent/KR20230044196A/ko active Pending
- 2021-06-23 JP JP2022580238A patent/JP7862331B2/ja active Active
- 2021-06-23 CN CN202180052532.8A patent/CN116194148A/zh active Pending
- 2021-06-23 EP EP21734544.6A patent/EP4171643B1/en active Active
- 2021-06-23 IL IL299349A patent/IL299349A/en unknown
- 2021-06-23 US US18/012,778 patent/US20230293562A1/en active Pending
-
2026
- 2026-04-27 JP JP2026073994A patent/JP2026126321A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4355369B1 (en) | Conjugate of saponin, oligonucleotide and galnac | |
| JPH10501237A (ja) | オリゴヌクレオチドのためのシクロデキストリン細胞送達系 | |
| US20070060499A1 (en) | Chloroquine combination drugs and methods for their synthesis | |
| JP2023532040A5 (cg-RX-API-DMAC10.html) | ||
| JP2022546055A5 (cg-RX-API-DMAC10.html) | ||
| AU2013262415B2 (en) | Oligonucleotide chelate complex methods | |
| CN113454221A (zh) | 含有三元环的双链核酸抑制剂分子 | |
| TW202113081A (zh) | 用於治療α-1抗胰蛋白酶缺乏症(AATD)的方法 | |
| CA3183881A1 (en) | Therapeutic combination of galnac-oligonucleotide conjugate and saponin, and uses thereof | |
| JP2023532681A5 (cg-RX-API-DMAC10.html) | ||
| JP2022542075A5 (cg-RX-API-DMAC10.html) | ||
| WO2023208109A1 (zh) | 用于抑制HSD17B13表达的siRNA、其缀合物和药物组合物及其用途 | |
| US20060040879A1 (en) | Chloroquine coupled nucleic acids and methods for their synthesis | |
| JP2023542500A5 (cg-RX-API-DMAC10.html) | ||
| TW202237189A (zh) | 具有增強之肝靶向的s抗原運輸抑制寡核苷酸聚合物之接合物 | |
| JP2023532679A5 (cg-RX-API-DMAC10.html) | ||
| EP4171643B1 (en) | Therapeutic combination of galnac-oligonucleotide conjugate and saponin, and uses thereof | |
| CN118512601A (zh) | 双链核酸-半乳糖胺-胆固醇化合物及其应用 | |
| EP4210760B1 (en) | Conjugate of saponin, oligonucleotide and galnac | |
| WO2006123631A1 (ja) | Rna含有組成物 | |
| HK40128805A (en) | Therapeutic combination of galnac-oligonucleotide conjugate and saponin, and uses thereof | |
| HK40110483A (en) | Conjugate of saponin, oligonucleotide and galnac | |
| HK40110483B (en) | Conjugate of saponin, oligonucleotide and galnac | |
| JP2025514180A5 (cg-RX-API-DMAC10.html) | ||
| HK40129944A (zh) | Galnac和皂苷的缀合物、包含所述缀合物和galnac-寡核苷酸缀合物的治疗性组合物 |